| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.32 | 8e-13 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.31 | 8e-10 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-07 |